• SENSEX 78,890.97
    1,589.57 (+2.06%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,850.00 1,878.00(%)
  • ITC
    277.30 252.80(%)
  • Tube Investments
    2,227.65 2,006.00(%)
  • Axis Bank
    1,274.00 1,418.30(%)
  • Reliance Industries
    1,325.00 1,611.20(%)
  • HDFC Life Insur.
    546.00 788.50(%)
  • Aurobindo Pharma
    1,748.85 1,739.95(%)
  • Lenskart Solut.
    767.40 725.00(%)
  • HDFC Bank
    762.80 1,017.90(%)
  • Titan Company
    4,858.90 5,187.45(%)
  • Petronet LNG
    320.00 326.40(%)
  • CG Power & Ind
    812.40 525.50(%)
  • Jio Platforms
    1,442.00 1,490.00(%)
  • Saregama India
    613.80 305.65(%)
  • Multi Comm. Exc.
    3,395.00 3,537.00(%)
  • Tonbo Imaging
    1,460.00 1,343.80(%)
  • Larsen & Toubro
    4,071.00 4,440.00(%)
  • Bajaj Finance
    1,053.90 1,177.60(%)
  • Cummins India
    4,036.95 3,883.30(%)
  • Bajaj Auto
    10,750.10 12,470.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unichem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 577.0
  • ISIN : INE351A01035
505.45 2 (0.42%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    490.45

  • Today’s High

    542.10

  • Open

    508.85

  • Perv Close

    503.35

  • 52W Low

    278.20

  • 52W High

    687.20

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    3,558.66

  • Div & Yield %

    0.00

  • Book Value(₹)

    373.14

  • Debt-Equity Ratio

    0.42

  • AGM Date

    04-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    3,558.66

  • RONW (%)

    -1.79

  • ROCE (%)

    -0.23

Score Board

  • Equity (₹ in Cr.)

    14.08

  • BV (₹)

    373.10

  • Sales( ₹ in Cr.)

    1,412.29

  • NP (in Cr.)

    -15.57

  • NP Var(%)

    -110.0

  • Div%

    0.0

  • CPS (₹)

    14.70

  • EPS (₹)

    -2.20

  • Traded Value (₹ in Lakhs)

    3,548.80

  • 52 Week High

    687.20

  • 52 Week Low

    278.20

  • Price BSE

    504.0

  • Price NSE

    505.00

  • Market Capital( in Cr.)

    3,548.80

  • P/C Ratio

    34.30

  • P/E Ratio

    -227.90

  • Price Vs.BV

    -2.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,412.29 1,735.70 1,442.16 1,072.43 942.93 1,123.97
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,412.29 1,735.70 1,442.16 1,072.43 942.93 1,123.97
Other Income 363.54 44.83 98.40 41.85 42.07 47.37
Stock Adjustments 7.28 33.33 26.35 -22.01 52.79 16.73
Total Income 1,783.11 1,813.86 1,566.91 1,092.27 1,037.79 1,188.07
EXPENDITURE :            
Raw Materials 672.64 830.62 717.82 501.86 436.27 449.67
Power and Fuel Cost 105.32 106.63 105.64 101.41 77.12 67.95
Employee Cost 277.22 287.51 283.15 270.86 250.79 234.04
Other Manufacturing Expenses 95.42 78.10 74.62 70.61 73.49 64.48
Selling and Administration Expenses 195.50 190.81 213.59 194.89 192.65 225.80
Miscellaneous Expenses 96.77 21.48 148.40 116.36 8.95 3.28
Employee Benefit Expenses 277.22 287.51 283.15 270.86 250.79 234.04
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,442.87 1,515.15 1,543.22 1,256.00 1,039.27 1,045.23
Operating Profit 340.24 298.71 23.69 -163.73 -1.49 142.84
Interest 11.80 7.62 10.42 9.38 2.07 1.30
Gross Profit 328.44 291.09 13.27 -173.11 -3.56 141.54
Depreciation 119.03 108.41 105.45 105.98 83.19 75.89
Profit Before Tax 209.41 182.68 -92.18 -279.09 -86.75 65.65
Current Tax 0.44 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 50.03 19.72 0.00 20.61 -31.32 11.56
Reported Net Profit 158.94 162.96 -92.18 -299.70 -55.43 54.08
Extraordinary Items 174.51 4.42 -55.94 -103.16 -0.25 0.02
Adjusted Net Profit -15.57 158.54 -36.24 -196.54 -55.18 54.06
Adjustment below Net Profit -1.38 0.00 0.00 121.81 0.00 0.00
P & L Balance brought forward 2,445.03 2,279.18 2,359.31 2,565.36 2,648.96 2,623.04
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 -2.89 -12.05 28.16 28.16 28.16
P & L Balance carried down 2,602.59 2,445.03 2,279.18 2,359.31 2,565.36 2,648.96
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 200.00 200.00 200.00
Dividend Per Share(Rs) 0.00 0.00 0.00 4.00 4.00 4.00
Earnings Per Share-Unit Curr 22.58 23.15 -13.09 -42.57 -7.87 7.68
Earnings Per Share(Adj)-Unit Curr 22.58 23.15 -13.09 -42.57 -7.87 7.68
Book Value 373.17 349.40 325.94 338.65 379.52 383.11
Book Value(Adj)-Unit Curr 373.17 349.40 325.94 338.65 379.52 383.11

Shareholding Pattern

  • Promoter Group

    70.22%

  • Public Share Holding

    29.78%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 37,081,011 52.67 37,081,011 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,221,224 17.36 12,221,224 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 138,351 0.20 138,351 3
Others 0 0.00 0 0
Sub Total 49,440,586 70.22 49,440,586 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 22,954 0.03 22,454 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,902,227 2.70 1,901,727 48
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 153,628 0.22 153,628 2
Mutual Funds / UTI 6,088,210 8.65 6,088,210 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 350,246 0.50 350,246 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,517,265 12.10 8,516,265 60
2] Non Institution
Bodies Corporate 231,773 0.33 231,693 141
Clearing Members 16,849 0.02 16,849 15
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 500,023 0.71 500,023 589
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 421,121 0.60 421,121 702
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,294,565 1.84 626,440 5
Individuals holding nominal share capital up to Rs. 1 lakh 9,198,025 13.06 8,627,606 24,629
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,500 0.00 2,500 1
Others 748,454 1.06 748,454 1
Sub Total 12,447,899 17.68 11,209,275 26,096
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 70,405,750 100.00 69,166,126 26,164

Company Background

Unichem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Unichem Laboratories Ltd
  • BSE Code : 577.0
  • ISIN : INE351A01035

  • Incorporation Year

    1962

  • Registered Office

    47 Kandivli Industrial Estate
    Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66474100

  • FAX

  • Chairman

    Prakash A Mody

  • Managing Director

    Pabitra Bhattacharya

  • Company Secretary

  • Auditor

    N A Shah Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Unichem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unichem Labs. 504.05 1,475.19 1,412.29 21.34 -0.12
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77